Moreover, GSPT1 interacted with ELAVL1 and EIF4B, proteins associated with favorable AML outcomes, while KPNA1 negatively interacted with PPP1CA, a marker of poor prognosis, suggesting its role in modulating negative prognostic pathways in leukemia. The gene discussed is ELAVL1; the disease is leukemia.